Biblio Discovery — Demo Discovery Service

21 hasil untuk "Aleena Banerji"

Menampilkan 1–20 · 0,27 detik · RSS

  1. Artikel Jurnal

    Acute Allergic Reactions to mRNA COVID-19 Vaccines

    Kimberly G. Blumenthal; Lacey B. Robinson; Carlos A. Camargo dkk.

    JAMA · 2021 · Inggris · OpenAlex

    This study examines the incidence of acute allergic reactions to mRNA COVID-19 vaccine administrations in health care employees in Massachusetts.

  2. Artikel Jurnal

    Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2

    Kimberly G. Blumenthal; Esther E. Freeman; Rebecca R. Saff dkk.

    New England Journal of Medicine · 2021 · Inggris · OpenAlex Scopus

    Vaccine against SARS-CoV-2To the Editor: Baden et al. 1 report on a phase 3 clinical trial of the mRNA-1273 vaccine against SARS-CoV-2, and they provide information on immediate injection-site reactions, which were observed in 84.2% of the participants after the first dose.The trial also showed…

  3. Artikel Jurnal

    Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

    Marc A Riedl; Aleena Banerji; Michael E Manning dkk.

    Orphanet Journal of Rare Diseases, Vol. 13 No. 1 · 2018 · Inggris · DOAJ Scopus

    Abstract Background Real-world data on usage and associated outcomes with hereditary angioedema (HAE)-specific medications introduced to the United States (US) market since 2009 are very limited. The purpose of this retrospective study was to evaluate real-world treatment patterns of HAE-specific…

  4. Artikel Jurnal Teks lengkap

    US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema

    Paula Jane Busse; Sandra C. Christiansen; Marc A. Riedl dkk.

    The Journal of Allergy and Clinical Immunology In Practice · 2020 · Inggris · OpenAlex Scopus

    Scientific and clinical progress together with the development of effective novel therapeutic options has engendered multiple important changes in the diagnosis and management of hereditary angioedema (HAE). We now update and extend the 2013 United States Hereditary Angioedema Association Medical…

  5. Artikel Jurnal

    Impact of injectable HAE on-demand treatments on health-related quality of life: a patient and caregiver interview study

    Patrick F. K. Yong; Timothy J. Craig; Paula J. Busse dkk.

    Allergy, Asthma & Clinical Immunology, Vol. 21 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background Hereditary angioedema (HAE) attacks can be unpredictable, painful, and debilitating. Although studies described the burden of prophylactic HAE treatments on patient and caregiver health-related quality of life (HRQoL), few have explored the effects of injectable on-demand…

  6. Artikel Jurnal

    An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension

    Marc A. Riedl; Jonathan A. Bernstein; Timothy Craig dkk.

    Clinical and Translational Allergy, Vol. 7 No. 1 · 2017 · Inggris · DOAJ Scopus

    Abstract Background Hereditary angioedema (HAE) is characterized by recurrent attacks of subcutaneous or submucosal edema. Attacks are unpredictable, debilitating, and have a significant impact on quality of life. Patients may be prescribed prophylactic therapy to prevent angioedema attacks…

  7. Artikel Jurnal

    A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis

    Joan Mendivil; Maral DerSarkissian; Aleena Banerji dkk.

    Allergy, Asthma & Clinical Immunology, Vol. 19 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, recurring subcutaneous or submucosal swelling. Without effective therapy, HAE can negatively impact patients’ quality of life. Management of HAE includes on-demand treatment of attacks and short- and…

  8. Artikel Jurnal

    Expert Perspectives on Hereditary Angioedema: Key Areas for Advancements in Care across the Patient Journey

    Aleena Banerji M.D.; Murat Baş M.D.; Jonathan A. Bernstein M.D. dkk.

    Allergy & Rhinology, Vol. 7 · 2016 · Inggris · DOAJ

    Background Published literature documents the substantial burden of hereditary angioedema (HAE) with C1 inhibitor deficiency on the quality of life and work productivity of patients. However, despite advances in the field and the availability of guidelines to advise health care providers (HCP) on…

  9. Artikel Jurnal

    An International Delphi Study on Barriers to On‐Demand Treatment of Hereditary Angioedema Attacks

    Aleena Banerji; Emel Aygören‐Pürsün; Noemi‐Anna Bara dkk.

    Clinical and Translational Allergy, Vol. 16 No. 3 · 2026 · Inggris · DOAJ Scopus

    ABSTRACT Background Hereditary angioedema (HAE) is a rare inherited disorder characterized by unpredictable and potentially life‐threatening attacks of swelling. This international Delphi panel aimed to address questions related to on‐demand treatment of HAE attacks. Methods A modified Delphi…

  10. Artikel Jurnal

    Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

    William R. Lumry; Bruce Zuraw; Marco Cicardi dkk.

    Orphanet Journal of Rare Diseases, Vol. 16 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Long-term prophylaxis with subcutaneous C1-inhibitor (C1-INH[SC]; HAEGARDA, CSL Behring) in patients with hereditary angioedema (HAE) due to C1-INH deficiency (C1-INH-HAE) was evaluated in an open-label extension follow-up study to the international, double-blind…

  11. Artikel Jurnal Teks lengkap

    The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

    Marcus Maurer; Markus A.K. Magerl; Stephen Betschel dkk.

    Allergy · 2022 · Inggris · OpenAlex Scopus

    Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and…

    Juga tersedia di: DOAJ

  12. Artikel Jurnal

    Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's

    Jonathan A. Bernstein, MD; Ignacio Ansotegui, MD, PhD; Riccardo Asero, MD dkk.

    World Allergy Organization Journal, Vol. 18 No. 7 · 2025 · Inggris · DOAJ Scopus

    Chronic spontaneous urticaria (CSU), with or without angioedema, is heterogeneous and comprised of different endotypes and phenotypes. Because acute urticaria will mostly resolve spontaneously, routine testing and laboratory evaluation is not required unless supported by the clinical history or…

  13. Artikel Jurnal

    The International/Canadian hereditary angioedema guideline

    Stephen Betschel; Karen Binkley; Rozita Borici-Mazi dkk.

    Allergy, Asthma & Clinical Immunology, Vol. 22 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract This update to the 2019 Canadian Hereditary Angioedema (HAE) Guideline broadens its focus to include the management of patients with HAE worldwide, building on its established international framework. It has been developed through a collaboration of Canadian and international HAE experts…

  14. Artikel Jurnal

    Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement

    Emilio Alvarez-Cuesta, MD, PhD, MQM; Ricardo Madrigal-Burgaleta, LMS, MD, PhD; Ana D. Broyles, MD dkk.

    World Allergy Organization Journal, Vol. 15 No. 6 · 2022 · Inggris · DOAJ Scopus

    Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave patients and doctors in a difficult position where an essential treatment or intervention has to be suspended. Even if virtually any intravenous medication can potentially trigger a life-threatening DHR…

  15. Artikel Jurnal

    The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities

    Daniel O. Vázquez, MD; Pedro Giavina-Bianchi, MD, PhD; Darío Josviack, MD dkk.

    World Allergy Organization Journal, Vol. 19 No. 5 · 2026 · Inggris · DOAJ Scopus

    The 2025 World Allergy Organization (WAO) Guidelines for the Classification, Diagnosis, and Treatment of Hereditary Angioedema (HAE) with Consideration of Worldwide Disparities provide a comprehensive, evidence-informed, and globally applicable framework for the care of this rare and potentially…